NEW YORK (GenomeWeb) – Private DNA synthesis firm Twist Bioscience said today that it has closed a $61 million Series D round of financing with a group of existing and new investors.

Investors included Arch Overage Fund, Merieux Developpement, Cormorant Asset Management, Fidelity Management and Research Company, and Foresite Capital Management. Other investors included Arch Venture Partners, WuXi Healthcare Ventures, Illumina, Nick and Joby Pritzker, Paladin Capital Group, Yuri Milner, and Boris Nikolic.